Novel Transarterial Biomimetic-Based Nanoparticles for the Treatment of Hepatocellular Carcinoma

Gastroenterology. 2016 Feb;150(2):312-4. doi: 10.1053/j.gastro.2015.12.022. Epub 2015 Dec 19.

Authors

Riccardo Lencioni¹, Filip Braet²

Affiliations

¹ University of Miami, Miller School of Medicine, Interventional Oncology Research and Sylvester Comprehensive Cancer Center, Miami, Florida. Electronic address: rlencioni@med.miami.edu.
² School of Medical Sciences (Discipline of Anatomy and Histology), The Bosch Institute and Cellular Imaging Facility, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

PMID: 26710988
DOI: 10.1053/j.gastro.2015.12.022

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Antineoplastic Agents / administration & dosage*
Carcinoma, Hepatocellular / drug therapy*
Docosahexaenoic Acids / administration & dosage*
Drug Carriers*
Lipoproteins, LDL / administration & dosage*
Liver Neoplasms / drug therapy*
Nanoparticles*

Substances

Antineoplastic Agents
Drug Carriers
Lipoproteins, LDL
Docosahexaenoic Acids